4sight Health December 1, 2021
David Burda


As I’ve said too many times to count, I’m not much for healthcare middlemen—distributors, benefits managers, wholesalers and group purchasing organizations—as I believe they add costs to the system rather than take costs out of the system as they profess in their value propositions. These middlemen have both hands out along the entire supply chain and grab as much cash as they can for themselves, their executives, their shareholders and their owners. 

A great example of this, courtesy of a recent study in JAMA Health Forum, helps explain why prices for insulin to treat diabetes are so high. So high that a provision in the Build Back Better bill passed by the House and pending in the...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: Employer, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Pricing / Spending, Provider, Supply Chain, Survey / Study, Technology, Trends
Mass General dinged for spending growth by state regulator
The Forest for the Trees: National Health Expenditures and Healthcare Reform
Billionaire Mark Cuban steps up assault on US medicine prices
Book Review: The Right Price
Health cost regulator reprimands dominant Mass. hospital system